Conditions: Pulmonary Disease, Chronic Obstructive; Asthma
Interventions: Drug: LAS190792 Dose 1; Drug: LAS190792 Dose 2; Drug: LAS190792 Dose 3; Drug: LAS190792 Dose 4; Drug: LAS190792 Dose 5; Drug: LAS190792 Dose 6; Drug: LAS190792 Dose 1 (Part 2); Drug: LAS190792 Dose 2 (Part 2); Drug: Tiotropium 18 ?g; Drug: Indacaterol 150 ?g; Drug: Placebo
Sponsor: Almirall, S.A.
Recruiting – verified February 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days